International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

30 September 2014

Summary

 

IBT Portfolio NAV (m)

218

Number of Portfolio Companies

90

Quoted Investments

64

Unquoted Investments

26

 

Quoted / Unquoted Split
NAV by Geography

Quoted

92%

United States / Canada

87%

Unquoted

8%

Europe

13%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

78%

Large-Cap (>$10bn)

49%

Medical Devices

4%

Mid-Cap (>$1bn, <$10bn)

31%

Specialty Pharma

12%

Small-Cap (<$1bn)

12%

Life Sciences, Tools

6%

Unquoted

8%

Total100%

Total

100%

 

 

NAV by Development Phase
NAV by Portfolio Profitability

 

 

 

Marketed

63%

Profitable

58%

Regulatory

7%

Turning Profitable 2014

7%

Phase 3

17%

Unprofitable

35%

Phase 2

9%

Total

100%

Phase 1

1%

 

Other

3%

 

Total

100%